Reboot biomedical R&D in the global public interest
by Soumya Swaminathan et al.Inequitable access to the fruits of research during the COVID-19 pandemic highlights the urgency — and feasibility — of overhauling the R&D system.
8th March 2022 •
comment
Submit an article
We welcome contributions from members. Please submit an article for review by our editorial team.
Upload nowCategories
- Arbovirus (5)
- biomedical research (1)
- Chikungunya (1)
- Child Health (1)
- Cohort studies (2)
- Communication (1)
- Community Engagement (1)
- Coronavirus (8)
- COVID-19 (WEPHREN Resources) (41)
- Data Analysis (1)
- Data Management (1)
- Drug safety (1)
- Epidemics (1)
- Global Health (4)
- GPP - social & political (1)
- Health Inequality (1)
- HIV/AIDS (2)
- Infectious diseases (7)
- Latin America (12)
- Malaria (1)
- Mental Health (2)
- Microbiology (1)
- Non-communicable Disease (1)
- Nutrition (2)
- Pandemic preparedness (4)
- Pediatric (1)
- Pneumonia (2)
- Public Attitudes (1)
- Public Health (1)
- Qualititative Research (1)
- social protection (1)
- Social Vulnerabilities (2)
- Study Protocols (2)
- Test Evaluations (1)
- Tests (1)
- Traditional medicine safety (1)
- universal health coverage (1)
- Vacccine Production (4)
- Vaccine Efficacy (6)
- Vaccine safety (2)
- Women's Health (1)
- zika (9)